(Q36025666)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

The Safety of Eplerenone in Hemodialysis Patients: A Noninferiority Randomized Controlled Trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Philip James Devereaux

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

4

Joe Bueti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Michael Walsh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Braden Manns

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Christian Rabbat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jessica Tyrwhitt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jackie Bosch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Peggy Gao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ron Wald

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Amit X Garg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

2 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

Clinical Journal of the American Society of Nephrology

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

1602-1608

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

Spironolactone for heart failure with preserved ejection fraction

18 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Long-term effects of spironolactone in peritoneal dialysis patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

End-stage renal disease in the United States: an update from the United States Renal Data System

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Serious adverse events experienced by patients with chronic heart failure taking spironolactone

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Trials to assess equivalence: the importance of rigorous methods

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Spironolactone in chronic hemodialysis patients improves cardiac function.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Is spironolactone safe for dialysis patients?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Safety of low-dose spironolactone administration in chronic haemodialysis patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559523

Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients

23 September 2018

1 reference

12 December 2020

Effect of haemodialysis on plasma ADH levels, plasma renin activity and plasma aldosterone levels in patients with end-stage renal disease

1 reference

12 December 2020

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension

1 reference

12 December 2020

Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis

1 reference

12 December 2020

Plasma aldosterone in hypertensive patients on chronic hemodialysis: distribution, determinants and impact on survival

1 reference

12 December 2020

Effect of eplerenone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric chronic hemodialysis patients - a pilot study

1 reference

12 December 2020

Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.12371214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138259%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

PubMed publication ID

26138259

1 reference